Singapore: Patrys released additional data from the first cohort of multiple myeloma patients treated with PAT-SM6 in th...
Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annua...
Singapore: Clinuvel Pharmaceuticals commenced its confirmatory phase III clinical trial of its novel drug SCENESSE (afam...
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...
Singapore: Senz Oncology announced that the ï¬rst patient has commenced treatment in a phase I/II clinical evaluati...
Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to e...
Life Sciences Queensland (LSQ), Australia, offers opportunity for industry stakeholders to come together and cooperate t...
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Brisbane-based pharma firm Alchemia has appointed Mr Charles (Charlie) Walker as its chief executive officer....
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...
Singapore: Associate Professor Tiziano Barberi and Dr Isabella Mengarelli from the Australian Regenerative Medicine Inst...
Singapore: US-based Echo Therapeutics, a company developing its needle-free Symphony tCGM System as a non-invasive, wire...
Singapore: Australian biotechnology company Minomic is all set to launch two overseas trials of its MiStat prostate canc...
Singapore: According to a survey by Accenture, majority of Australian doctors (77 percent) have highlighted that sharing...
‎Singapore: ReSearch Pharmaceutical Services, a clinical research firm, has appointed Mr Marc Wolff as its chief f...
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...
